Uncapped Capital Protection on NOVARTIS SWISSCOM And
2
Uncapped Capital Protection on NOVARTIS SWISSCOM and ROCHE 90% Capital Protection - St rike at 90% - 181% Participation - 6 Mo nths - CHF Details Redemption Issuer EFG Financial Products Guarantor EFG International Collateral-Secured Investment On 12.03.20 10 Client pays CHF 1000 (Denomination) Rating: Fitch A No Issuer Risk Underlying NOVARTIS AG- RE G SWI SSCOM AG-RE G On 13.09.2010 Client receives: Bbg Ti cke r NOVN VX Equity SCMN VX Equity ROG VX Equity Initial Fixing Leve l CHF 59.62 CHF 367.92 CHF 179.07 Strike Level (90%) CHF 53.66 CHF 331.13 CHF 161.16 Initial Fixing Date 26.02.10 Payment Date 12.03.10 Valuation Date 26.08.10 Maturity 13.09.10 Details Cash Settlement 181% Leverage on the upside ISIN CH0110622518 Valoren 11062251 SIX Symbol EFGAH Characteristics 1. Y our capital is guaranteed at 90% 1. Y our are exposed to interest rates v ariations 2. Pl ai n vanil la part ici pati on of 18 1% in the i ncrease of the Wors t p erf orm ing Underl yi ng 2. Y our are expo sed to volati li ty vari at ions 3. T he Strike Level is 10% lower than the Initial Fixing Level 3. The pay-off is only v alid at maturity 4. Only 10% of your capital is at risk 5. Secondary market as liquid as equity markets 6. COSI Product: The investor does not bear issuer's credit risk Historical Chart importer depuis la deuxieme feuille Contacts Filippo Colombo Nathanael Gabay Bruno Frateschi Sofiane Zaiem Stan islas Perromat +41 22 918 70 05 Alejandro Po u Cut uri Live pri ces at www.efgfp.com +377 93 15 11 66 Worst case scenario__________________________ _________________________________ Risks__________________________________________________________________________ Underly ing_________________________________ _____________________________________ _____________________________________ _____________________________________ ________ Opportunities______________________________________________________________ Best c ase scenario_______________________ __________________________________ The Investor will receive a Cash Settlement in CHF equal to: Denomination x 90% The Investor will receive a Cash Settlement in CHF linked to the worst performer equal to: Denomination x (90% + 18 1% x (Final Fixing Level - Strike Level) / Initial fixing Level) Scenario 1: If at least one Underlying closes below the Strike Le vel on the Valuation Scenario 2: If all the Underlyi ngs are at or above their Strike Level law ).The Und erly ings´performan cein thepast does not co nstitutea guar anteefor their futur e performance.The financi alproducts' value is subject to market fluctua tion, what can lead to apartial or to tal loss o f t heinvested capital .The purch aseo f t hefinancia l products trigger s co sts and fees.EFG Finan cialProducts AG and/or another related company may operate as market maker for the financial products, may trade as principal, and may conclude hedging transactions. Such activity may influence the market price, the price movement, or the liquidity of the financial products. © EFG Financial Products AG All rights reserved. This pub licationserves onlyfor information purp oses andis not resear ch;it constitutes neith er a recommenda tion fo r the purchaseof finan cialinstrumen ts nor an offer or an invi tation fo r an offer. No responsi bilityis takenfo r the correctness of this information.The financia linstruments mentioned in this docume nt are deri vative instruments. They do not quali fy as units of a collective investment scheme pursuant to art. 7 et seqq. of the Swiss Federal Act on Co llective Investment Schemes (CISA) and are therefore neither registered nor supervised by the Swiss Financial Market Superviso ry Authority FINMA. Investors bear the credit risk of the issuer /guara ntor. Before investin g in deri vative instrumen ts,Investors arehighl y recommended to ask their financi aladvisor f or advice specificall yfo cused on the Investor´s financi al situation;the informationcontained inthis document does not substitute suchadvice. This publi cation does not constitutea simpli fied prospe ctus pursuant to a rt. 5C ISA, or alisting prospectus pursuant to art.652a or 11 56 of the Swiss Codeo f Obligations.The relevant product documentatio n can be obtained directlyat EFG Financial Product s AG:T el. + 41(0)58 80 0 1 111 , Fax+41(0)58800 1 010,o r via e -mail: [email protected]. Selling re strict ions apply for Europe, HongKo ng, Singapore, the USA, U S persons, and the United Kingdom (the issuance is subject to Swiss Redemption: 90% of the invested capital + 181% participation on the upside (From 90%) The Worst performing Underlying closes far above the Strike Le vel on the V aluation D ate T he Worst perf or min g Und erly in g cl oses be lo w th e Str ik e Level on th e Valu at io n Date Redemption: 90% of the inv ested capital ROCHE H OLDING AG-GENUSS CHEIN - Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, ophthalmics, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; generics; and over-the-counter, vision, and animal health pro ducts. - Swisscom AG operates public telecommunications networks and offers network application services. The Company provides local, long-distance, and mobile telephone services, integrated voice and data digital services, network solutions to national and international telecommunications operators, and Internet access services, and owns and operates pay telephones. - Roche Holdin g AG develops and manu fact ures pharmaceut ical and diagnos tic produ cts . The Company produces prescription drugs in th e areas of cardiov ascu lar, infectious , autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplan tation, and the c entral nervous system. 60% 70% 80% 90% 100% 110% 120% May-08 Aug-08 Nov-08 Feb-09 May-09 Aug-09 Nov-09 Feb-10 Novartis Swisscom Roche Sofiane Zaiem +41 22 918 70 05 Redemption: 90% of the invested capital + 181% of the worst peformer Underlying Redemption: 90% of the invested capit al 181% of the increase Strike level at 90%
-
Upload
api-25889552 -
Category
Documents
-
view
221 -
download
0
Transcript of Uncapped Capital Protection on NOVARTIS SWISSCOM And
8/14/2019 Uncapped Capital Protection on NOVARTIS SWISSCOM And
http://slidepdf.com/reader/full/uncapped-capital-protection-on-novartis-swisscom-and 1/1
ncapped Capital Protection on NOVARTIS SWISSCOM and ROCHE
0% Capital Protection - Strike at 90% - 181% Participation - 6 Months - CHF
Details Redemption
uer EFG Financial Products
arantor EFG International Collateral-Secured Investment On 12.03.2010 Client pays CHF 1000 (Denomination)
Rating: Fitch A No Issuer Risk
derlying NOVARTIS AG-REG SWISSCOM AG-REG On 13.09.2010 Client receives:
g Ti cker NOVN VX Equity SCMN VX Equity ROG VX Equity
tial Fixing Level CHF 59.62 CHF 367.92 CHF 179.07
ke Level (90%) CHF 53.66 CHF 331.13 CHF 161.16
tial Fixing Date 26.02.10
yment Date 12.03.10
luation Date 26.08.10
aturity 13.09.10
tails Cash Settlement 181% Leverage on the upside
N CH0110622518
loren 11062251
X Symbol EFGAH
haracteristics
our capital is guaranteed at 90% 1. Your are exposed to interest rates variations
ain vanilla participation of 181% in the increase of the Worst performing Underlying 2. Your are exposed to volatility variations
he Strike Level is 10% lower than the Initial Fixing Level 3. The pay-off is only valid at maturity
Only 10% of your capital is at risk
econdary market as liquid as equity markets
COSI Product: The investor does not bear issuer's credit risk
istorical Chart
importer depuis la deuxieme feuille
ontactsppo Colombo Nathanael Gabay
no Frateschi Sofiane Zaiem
nislas Perromat +41 22 918 70 05
jandro Pou Cuturi Live prices at www.efgfp.com77 93 15 11 66
Worst case scenario___________________________________________________________
Risks__________________________________________________________________________
erlying________________________________________________________________________________________________________________________________________________________
portunities______________________________________________________________
case scenario_________________________________________________________
The Investor will receive a Cash Settlement in CHF equal to:
Denomination x 90%
The Investor will receive a Cash Settlement in CHF linked to the worst performer equal
to:
Denomination x (90% + 181% x (Final Fixing Level - Strike Level) / Initial fixing Level)
Scenario 1: If at least one Underlying closes below the Strike Level on the Valuation
Scenario 2: If all the Underlyings are at or above their Strike Level
he Underlyings´performancein thepast does not co nstitutea guaranteefor their future performance.The financialproducts' value is subject to market fluctuation, what can lead to apartial or to tal loss o f t heinvested capital.The purchaseo f t hefinancial products triggers co sts and fees.EFG FinancialProducts AG and/or
er related company may operate as market maker for the financial products, may trade as principal, and may conclude hedging transactions. Such activity may influence the market price, the price movement, or the liquidity of the financial products. © EFG Financial Products AG All rights reserved.
ublicationserves onlyfor information purposes andis not research;it constitutes neither a recommendation fo r the purchaseof financialinstruments nor an offer or an invitation fo r an offer. No responsibilityis takenfo r the correctness of this information.The financialinstruments mentioned in this document are derivative
ments. They do not qualify as units of a collective investment schem e pursuant to art. 7 et seqq. of the Swiss Federal Act on Co llective Investment Schemes (CISA) and are therefore neither registered nor supervised by the Swiss Financial Market Superviso ry Authority FINM A. Investors bear the credit risk of the
guarantor. Before investing in derivative instruments,Investors arehighly recommended to ask their financialadvisor f or advice specificallyfo cused on the Investor´s financial situation;the informationcontained inthis document does not substitute suchadvice. This publication does not constitutea simplified prospectus
ant to art. 5C ISA, or alisting prospectus pursuant to art.652a or 1156 of the Swiss Codeo f Obligations.The relevant product documentatio n can be obtained directlyat EFG Financial Product s AG:T el. +41(0)58 800 1111, Fax+41(0)58800 1010,o r via e-mail: [email protected]. Selling restrict ions apply for Europe, HongKo ng,
pore, the USA, US persons, and the United Kingdom (the issuance is subject to Swiss
emption: 90% of the invested capital + 181% participation on the upside (From 90%)
Worst performing Underlying closes far above the Strike Level on the V aluation DateThe Worst performing Underlying closes below the Strike Level on the Valuation
Date
Redemption: 90% of the inv ested capital
ROCHE HOLDING AG-GENUSSCHEIN
ovartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases;cology, neuroscience, transplantation, ophthalmics, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; generics; and over-the-counter,
on, and animal health products.
wisscom AG operates public telecommunications networks and offers network application services. The Company provides local, long-distance, and mobile telephone services,
grated voice and data digital services, network solutions to national and international telecommunications operators, and Internet access services, and owns and operates pay
phones.
oche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious,
oimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.
60%
70%
80%
90%
100%
110%
120%
May-08 Aug-08 Nov-08 Feb-09 May-09 Aug-09 Nov-09 Feb-10
Novartis
Swisscom
Roche
Sofiane Zaiem+41 22 918 70 05
Redemption: 90% of the invested capital + 181% of the worst
peformer Underlying
Redemption: 90% of the invested capital
181% of the increase
Strike level at 90%
